Download the full EMR valuation report (PDF) — free

DCF fair value, Graham number, EPV, key multiples and growth rates in one clean PDF.

EMR Valuation

Fair Value Summary

Daily Price — EMR

$143.07 +12.9% (1Y)

PEG Ratio

Overvalued

7.28x

01 (fair)23+

P/E Ratio33.0x

TTM EPS$4.33

EPS Growth Rate4.5%

Source: 5-Year EPS CAGR

Interpretation

<1 Undervalued

1–2 Fair

>2 Overvalued

PEG = P/E ÷ Annual EPS Growth Rate (%). Peter Lynch's growth-adjusted value metric.

EV/EBITDA

Overvalued

17.8x

010 (cheap)1530+

Enterprise Value$86.0B

EBITDA (Annual)$4.8B

Sector Median PE58.6x

Interpretation

<10 Cheap

10–15 Fair

>15 Expensive

EV/EBITDA = Enterprise Value ÷ EBITDA. Capital-structure neutral — preferred by professional investors.

Price/Sales

Overvalued

4.45x

0136+

Market Cap$80.1B

Annual Revenue$18.0B

Current Price$143.07

Interpretation

<1 Very Cheap

1–3 Fair

>3 Expensive

P/S = Market Cap ÷ Revenue. Useful for growth/unprofitable companies. SaaS/high-growth norms higher.

Price/Book

Overvalued

3.97x

0136+

Meaningful metric for Industrials

Current Price$143.07

Book Value/Share$36.04

Total Equity$20.3B

Interpretation

<1 Undervalued

1–3 Fair

>3 Expensive

P/B = Price ÷ Book Value per Share. Essential for banks, REITs, and asset-heavy companies.

Graham Number

Overvalued

$57.45

149.0% premium vs current price

Current Price$143.07

EPS$4.07

Book Value / Share$36.04

Interpretation

Price < Graham → Undervalued

Price > Graham → Overvalued

√(22.5 × EPS × Book Value/Share) — Benjamin Graham's intrinsic value estimate.

Earnings Power Value

Overvalued

$34.44

-75.9% vs current price ($143.07)

⚠️ Normal returns

Current Price$143.07

WACC8.0%

NOPAT$2.5B

Book Value / Share$36.04

Greenwald EPV assumes zero future growth — this is the floor value of the business as a going concern.

Valuation Parameters

Loading history...

Download the full EMR valuation report (PDF) — free

DCF fair value, Graham number, EPV, key multiples and growth rates in one clean PDF.

EMR Valuation

Fair Value Summary

Daily Price — EMR

$143.07 +12.9% (1Y)

PEG Ratio

Overvalued

7.28x

01 (fair)23+

P/E Ratio33.0x

TTM EPS$4.33

EPS Growth Rate4.5%

Source: 5-Year EPS CAGR

Interpretation

<1 Undervalued

1–2 Fair

>2 Overvalued

PEG = P/E ÷ Annual EPS Growth Rate (%). Peter Lynch's growth-adjusted value metric.

EV/EBITDA

Overvalued

17.8x

010 (cheap)1530+

Enterprise Value$86.0B

EBITDA (Annual)$4.8B

Sector Median PE58.6x

Interpretation

<10 Cheap

10–15 Fair

>15 Expensive

EV/EBITDA = Enterprise Value ÷ EBITDA. Capital-structure neutral — preferred by professional investors.

Price/Sales

Overvalued

4.45x

0136+

Market Cap$80.1B

Annual Revenue$18.0B

Current Price$143.07

Interpretation

<1 Very Cheap

1–3 Fair

>3 Expensive

P/S = Market Cap ÷ Revenue. Useful for growth/unprofitable companies. SaaS/high-growth norms higher.

Price/Book

Overvalued

3.97x

0136+

Meaningful metric for Industrials

Current Price$143.07

Book Value/Share$36.04

Total Equity$20.3B

Interpretation

<1 Undervalued

1–3 Fair

>3 Expensive

P/B = Price ÷ Book Value per Share. Essential for banks, REITs, and asset-heavy companies.

Graham Number

Overvalued

$57.45

149.0% premium vs current price

Current Price$143.07

EPS$4.07

Book Value / Share$36.04

Interpretation

Price < Graham → Undervalued

Price > Graham → Overvalued

√(22.5 × EPS × Book Value/Share) — Benjamin Graham's intrinsic value estimate.

Earnings Power Value

Overvalued

$34.44

-75.9% vs current price ($143.07)

⚠️ Normal returns

Current Price$143.07

WACC8.0%

NOPAT$2.5B

Book Value / Share$36.04

Greenwald EPV assumes zero future growth — this is the floor value of the business as a going concern.

Valuation Parameters

Loading history...